GlassScriptPhysician profile
Victor J Mazza
NPI 1841358066
$8,698.86
in general payments reported to CMS, 2019-2025
34 companies · $2,097 in 2025
The $2,097 reported for 2025 was less than what a typical Clinical Cardiac Electrophysiology provider received nationally (typical 2025 total: $2,477).
See the full distribution for Clinical Cardiac Electrophysiology
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,195 · 2020: $417 · 2021: $1,313 · 2022: $2,788 · 2023: $394 · 2024: $496 · 2025: $2,097.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,737 · Consulting Fee: $1,250.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,737.05 |
| Consulting Fee | $1,250.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $2,753.97 | 2019-2025 | Aveir |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $1,292.31 | 2019-2025 | Lifevest |
| Vivaquant INC, Dba Rhythm Express | $1,250.00 | 2025 | Rhythm Express |
| Medtronic, INC. | $941.60 | 2021-2024 | Claria Mri Quad Crt-D Surescan, Azure Xt Dr Mri Surescan, N/A |
| Intra-Sana Laboratories | $427.58 | 2024-2025 | Reltone 400 Mg, Glycate, Reltone 200 Mg |
| Medtronic Vascular, INC. | $350.61 | 2019 | |
| Boston Scientific Corporation | $271.36 | 2019-2023 | Resonate El Icd Vr, Watchman Access System |
| Novo Nordisk INC | $241.53 | 2022-2025 | Wegovy |
| Novartis Pharmaceuticals Corporation | $173.70 | 2019-2024 | |
| Merck Sharp & Dohme LLC | $130.61 | 2021-2025 | Verquvo |
| Heartflow, INC. | $100.74 | 2024-2025 | |
| Baxter Healthcare | $88.11 | 2025 | Hillrom - Cardiac Ambulatory Monitor, Hillrom - Carnation Ambulatory Monitor |
| E.R. Squibb & Sons, L.L.C. | $77.75 | 2019-2023 | Eliquis |
| Biosense Webster, INC. | $66.62 | 2019 | |
| Pfizer INC. | $64.95 | 2022-2023 |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $61.04 | 2019 | |
| Amgen INC. | $51.11 | 2019-2025 | Repatha, Repatha |
| Philips North America LLC | $42.04 | 2024-2025 | (Ck7) Extended Holter, Mcot |
| Altathera Pharmaceuticals LLC | $37.71 | 2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $34.98 | 2025 | Jardiance |
| Vifor Pharma, INC. | $25.69 | 2021 | |
| Inspire Medical Systems, INC. | $24.64 | 2025 | Inspire |
| Cvrx, INC. | $23.08 | 2021 | |
| Infobionic, INC | $19.18 | 2020 | |
| Kestra Medical Technology Services, INC. | $18.95 | 2025 | Assure Wcd |
| Biotronik INC. | $18.15 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $15.09 | 2025 | |
| Janssen Pharmaceuticals, INC | $14.83 | 2021 | |
| Lilly USA, LLC | $14.57 | 2025 | Mounjaro, Zepbound |
| Corcept Therapeutics | $14.24 | 2025 | Korlym |
| Lexicon Pharmaceuticals, INC. | $13.95 | 2024 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $13.83 | 2022 | |
| Astellas Pharma US INC | $12.22 | 2019 | |
| Althera Pharmaceuticals LLC | $12.12 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Victor Mazza listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.